These findings indicated that incorporating serum biomarkers such as AOPP, IL-6, and GDF15 with AHI significantly enhanced the diagnostic value of arteriosclerosis in patients with OSA. The gene discussed is GDF15; the disease is obstructive sleep apnea syndrome.